
DiaSorin SpA
MIL:DIA

DiaSorin SpA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
90.2
110.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does DiaSorin SpA hold over its rivals?
What risks and challenges
does DiaSorin SpA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of DiaSorin SpA.
Provide an overview of the primary business activities
of DiaSorin SpA.
What unique competitive advantages
does DiaSorin SpA hold over its rivals?
What risks and challenges
does DiaSorin SpA face in the near future?
Summarize the latest earnings call
of DiaSorin SpA.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for DiaSorin SpA.
Provide P/S
for DiaSorin SpA.
Provide P/E
for DiaSorin SpA.
Provide P/OCF
for DiaSorin SpA.
Provide P/FCFE
for DiaSorin SpA.
Provide P/B
for DiaSorin SpA.
Provide EV/S
for DiaSorin SpA.
Provide EV/GP
for DiaSorin SpA.
Provide EV/EBITDA
for DiaSorin SpA.
Provide EV/EBIT
for DiaSorin SpA.
Provide EV/OCF
for DiaSorin SpA.
Provide EV/FCFF
for DiaSorin SpA.
Provide EV/IC
for DiaSorin SpA.
Show me price targets
for DiaSorin SpA made by professional analysts.
What are the Revenue projections
for DiaSorin SpA?
How accurate were the past Revenue estimates
for DiaSorin SpA?
What are the Net Income projections
for DiaSorin SpA?
How accurate were the past Net Income estimates
for DiaSorin SpA?
What are the EPS projections
for DiaSorin SpA?
How accurate were the past EPS estimates
for DiaSorin SpA?
What are the EBIT projections
for DiaSorin SpA?
How accurate were the past EBIT estimates
for DiaSorin SpA?
Compare the revenue forecasts
for DiaSorin SpA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of DiaSorin SpA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of DiaSorin SpA against its competitors.
Analyze the profit margins
(gross, operating, and net) of DiaSorin SpA compared to its peers.
Compare the P/E ratios
of DiaSorin SpA against its peers.
Discuss the investment returns and shareholder value creation
comparing DiaSorin SpA with its peers.
Analyze the financial leverage
of DiaSorin SpA compared to its main competitors.
Show all profitability ratios
for DiaSorin SpA.
Provide ROE
for DiaSorin SpA.
Provide ROA
for DiaSorin SpA.
Provide ROIC
for DiaSorin SpA.
Provide ROCE
for DiaSorin SpA.
Provide Gross Margin
for DiaSorin SpA.
Provide Operating Margin
for DiaSorin SpA.
Provide Net Margin
for DiaSorin SpA.
Provide FCF Margin
for DiaSorin SpA.
Show all solvency ratios
for DiaSorin SpA.
Provide D/E Ratio
for DiaSorin SpA.
Provide D/A Ratio
for DiaSorin SpA.
Provide Interest Coverage Ratio
for DiaSorin SpA.
Provide Altman Z-Score Ratio
for DiaSorin SpA.
Provide Quick Ratio
for DiaSorin SpA.
Provide Current Ratio
for DiaSorin SpA.
Provide Cash Ratio
for DiaSorin SpA.
What is the historical Revenue growth
over the last 5 years for DiaSorin SpA?
What is the historical Net Income growth
over the last 5 years for DiaSorin SpA?
What is the current Free Cash Flow
of DiaSorin SpA?
Discuss the annual earnings per share (EPS)
trend over the past five years for DiaSorin SpA.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
IT |
![]() |
DiaSorin SpA
MIL:DIA
|
4.9B EUR | 13.9 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
231.9B USD | 22.3 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
200B USD | 65.2 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
152.1B USD | 35.3 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
146.4B USD | 25.3 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
111.5B USD | 13.4 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
51.8B EUR | 14 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
49B USD | 13 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
45.8B USD | 25.1 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.2B USD | 33.4 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
285.3B CNY | 22.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
IT |
![]() |
DiaSorin SpA
MIL:DIA
|
Average EV/EBITDA:
25.8
13.9
|
11%
|
1.3 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
22.3
|
13%
|
1.7 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
65.2
|
24%
|
2.7 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
35.3
|
21%
|
1.7 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
25.3
|
12%
|
2.1 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
13.4
|
5%
|
2.7 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
14
|
14%
|
1 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
13
|
11%
|
1.2 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
25.1
|
12%
|
2.1 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
33.4
|
12%
|
2.8 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
22.5
|
16%
|
1.4 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.